1-2 of 2
Michela Viltadi, MS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A New BCR-ABL1 Mutation (L248R) Is Highly Resistant to Imatinib, Bosutinib, Nilotinib and Dasatinib, but Can Be Inhibited by AP-24534 and DCC-2036.

Sara Redaelli, PhD, Luca Mologni, PhD, Roberta Rostagno, MS, Rocco Piazza, MD, PhD, Michela Viltadi, MS, Scott Wise, MS, Daniel Flynn, PhD, Carlo Gambacorti-Passerini, MD
Journal: Blood
Blood (2010) 116 (21): 3398.
https://doi.org/10.1182/blood.V116.21.3398.3398
Published: 2010
Journal Articles

Bosutinib is a Substrate of the ABC Efflux Transporter P-Glycoprotein.

Pietro Perini, MS, Sara Redaelli, PhD, Rocco Piazza, MD, Michela Viltadi, MS, Frank Boschelli, PhD, Carlo Gambacorti, MD
Journal: Blood
Blood (2009) 114 (22): 3763.
https://doi.org/10.1182/blood.V114.22.3763.3763
Published: 2009